New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Mereo BioPharma Group plc
MREO
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

497M

Biotechnology

Next Earning date - 26 Mar 2025

497M

Biotechnology

Next Earning date - 26 Mar 2025

3.01USD

Shape0.08 ( 2.73%)
sun-fogPre-market 2.96$arrow-left-down-0.06 (-1.83%)
Market Closed (as of Jan 31, 21:00 EDT)
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

-22%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

40%

Quote Panel

Shape
Updated February 6, 2025
1W 6.64 % 1M -14.63 % 3M -21.52 % 1Y -17.05 %

Key Metrics

Shape
  • Market Cap

    496.70M


  • Shares Outstanding

    154.73M


  • Share in Float

    142.11M


  • Dividende

    0


  • Earning Date

    26 Mar 2025


  • Price Target

    3.21


  • Average Volume

    1.06M


  • Beta

    0.97


  • Range

    2.525-5.02


  • Industry

    Biotechnology


  • Website

    https://www.mereobiopharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

MREO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$29M

ShapeNaN%

2025-Revenue

$0.02

Shape100%

2025-EPS

$12M

Shape15%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Cantor Fitzgerald

initialise

Previous: Not converted

2022-08-12

Now: Overweight

Needham

initialise

Previous: Not converted

2021-04-05

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.03
vs 0.01

Q1.23

arrow
arrow

N/A

-0.01
vs -0.14

Q2.23

arrow
arrow

N/A

-0.03
vs -0.05

Q3.23

arrow
arrow

N/A

-0.01
vs -0.02

Q4.23

arrow
arrow

N/A

-0.01
vs -0.03

Q1.24

arrow
arrow

N/A

-0.01
vs -0.01

Q2.24

arrow
arrow

N/A

-0.02
vs -0.03

Q3.24

arrow
arrow

N/A

-7.69
vs -0.01

Q4.24

arrow
arrow

N/A

-0.01
vs -0.01

Q1.25

arrow
arrow

+212%

0.01
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

832K  vs NA

Q1.23

arrow
arrow

+671%

3.6M  vs 462.4K

Q2.23

arrow
arrow

NA

8.8M  vs NA

Q3.23

arrow
arrow

-21%

533.4K  vs 675K

Q4.23

arrow
arrow

-57%

361.1K  vs 832K

Q1.24

arrow
arrow

-100%

NA  vs 3.6M

Q2.24

arrow
arrow

-100%

NA  vs 8.8M

Q3.24

arrow
arrow

-100%

NA  vs 533.4K

Q4.24

arrow
arrow

+7883%

28.8M  vs 361.1K

Q1.25

arrow
arrow

NA

28.6M  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-29%

-0.29
vs -0.20

Q1.23

arrow
arrow

-13%

-0.13
vs -0.29

Q2.23

arrow
arrow

-24%

-0.24
vs -0.13

Q3.23

arrow
arrow

-16%

-0.16
vs -0.24

Q4.23

arrow
arrow

-12%

-0.12
vs -0.16

Q1.24

arrow
arrow

-21%

-0.21
vs -0.12

Q2.24

arrow
arrow

-16%

-0.16
vs -0.21

Q3.24

arrow
arrow

-21%

-0.21
vs -0.16

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

61

61
vs 61

NA

Q1.23

arrow
arrow

59

59
vs 61

-3%

Q2.23

arrow
arrow

55

55
vs 59

-7%

Q3.23

arrow
arrow

57

57
vs 55

4%

Q4.23

arrow
arrow

67

67
vs 57

18%

Q1.24

arrow
arrow

84

84
vs 67

25%

Q2.24

arrow
arrow

81

81
vs 84

-4%

Q3.24

arrow
arrow

81

81
vs 81

NA

Earnings Growth

Latest News